The BSE Sensex crashed 1,018.20 points or 1.32 per cent to close at 76,293.60, while the broader NSE Nifty declined 309.80 points or 1.32 per cent to end at 23,071.80, marking their fifth consecutive session of losses. The selloff intensified in the afternoon session, with both indices touching intraday lows.
“Indian markets underperformed global indices as benchmark indices plunged over 1 per cent each on widespread selling, mainly ignited by worries over escalating tariff war after Trump imposed 25 per cent import tariffs on steel and aluminium, which would hurt India’s business prospects,” said Prashanth Tapse, Senior VP (Research) at Mehta Equities Ltd.
The market breadth was overwhelmingly negative, with 3,478 stocks declining against just 525 advances on the BSE. A staggering 479 stocks hit their 52-week lows, while only 55 touched their 52-week highs, highlighting the depth of the selloff.
Mid and small-cap stocks bore the brunt of the selling pressure, with the Nifty Midcap Select falling 2.70 per cent and broader market indices witnessing steeper declines. The Nifty Next 50 tumbled 2.50 per cent.
Among sectoral indices, financial services, healthcare, and realty were the worst hit. Eicher Motors emerged as the biggest loser among Nifty stocks, plunging 6.70 per cent, followed by Apollo Hospitals (-6.61 per cent) and Shriram Finance (-4.51 per cent). On the flip side, Adani Enterprises bucked the trend with a 1.32 per cent gain after announcing a strategic partnership with Mayo Clinic.
“The ongoing uncertainty surrounding US trade policies and tariffs, coupled with domestic economic growth concerns and persistent selling by FIIs, is dampening market sentiment,” noted Vinod Nair, Head of Research at Geojit Financial Services.
👉The Indian rupee showed some resilience, strengthening above 86.80 against the dollar after hitting a record low of 88.00 in the previous session. “Despite the recovery, volatility remains high, with rupee movement expected in the 86.40 - 87.25 range in the near term,” said Jateen Trivedi, VP Research Analyst at LKP Securities.
No comments:
Post a Comment